201 related articles for article (PubMed ID: 18940237)
1. Consequences of the DYT1 mutation on torsinA oligomerization and degradation.
Gordon KL; Gonzalez-Alegre P
Neuroscience; 2008 Dec; 157(3):588-95. PubMed ID: 18940237
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.
Beauvais G; Bode NM; Watson JL; Wen H; Glenn KA; Kawano H; Harata NC; Ehrlich ME; Gonzalez-Alegre P
J Neurosci; 2016 Oct; 36(40):10245-10256. PubMed ID: 27707963
[TBL] [Abstract][Full Text] [Related]
3. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
Gonzalez-Alegre P; Paulson HL
J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
[TBL] [Abstract][Full Text] [Related]
4. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.
Gonzalez-Alegre P; Bode N; Davidson BL; Paulson HL
J Neurosci; 2005 Nov; 25(45):10502-9. PubMed ID: 16280588
[TBL] [Abstract][Full Text] [Related]
5. TorsinA protein degradation and autophagy in DYT1 dystonia.
Giles LM; Li L; Chin LS
Autophagy; 2009 Jan; 5(1):82-4. PubMed ID: 18971629
[TBL] [Abstract][Full Text] [Related]
6. The role of torsinA in dystonia.
Granata A; Warner TT
Eur J Neurol; 2010 Jul; 17 Suppl 1():81-7. PubMed ID: 20590813
[TBL] [Abstract][Full Text] [Related]
7. Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope.
Giles LM; Chen J; Li L; Chin LS
Hum Mol Genet; 2008 Sep; 17(17):2712-22. PubMed ID: 18552369
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia.
Martin JN; Bair TB; Bode N; Dauer WT; Gonzalez-Alegre P
Neuroscience; 2009 Dec; 164(2):563-72. PubMed ID: 19665049
[TBL] [Abstract][Full Text] [Related]
9. Efficient RNA interference-based knockdown of mutant torsinA reveals reversibility of PERK-eIF2α pathway dysregulation in DYT1 transgenic rats in vivo.
Beauvais G; Watson JL; Aguirre JA; Tecedor L; Ehrlich ME; Gonzalez-Alegre P
Brain Res; 2019 Mar; 1706():24-31. PubMed ID: 30366018
[TBL] [Abstract][Full Text] [Related]
10. TorsinA and dystonia: from nuclear envelope to synapse.
Granata A; Schiavo G; Warner TT
J Neurochem; 2009 Jun; 109(6):1596-609. PubMed ID: 19457118
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar synaptogenesis is compromised in mouse models of DYT1 dystonia.
Vanni V; Puglisi F; Bonsi P; Ponterio G; Maltese M; Pisani A; Mandolesi G
Exp Neurol; 2015 Sep; 271():457-67. PubMed ID: 26183317
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy.
Gordon KL; Glenn KA; Bode N; Wen HM; Paulson HL; Gonzalez-Alegre P
Neuroscience; 2012 Nov; 224():160-71. PubMed ID: 22917612
[TBL] [Abstract][Full Text] [Related]
13. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
Hewett JW; Nery FC; Niland B; Ge P; Tan P; Hadwiger P; Tannous BA; Sah DW; Breakefield XO
Hum Mol Genet; 2008 May; 17(10):1436-45. PubMed ID: 18258738
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
Bragg DC; Kaufman CA; Kock N; Breakefield XO
Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
[TBL] [Abstract][Full Text] [Related]
15. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.
Misbahuddin A; Placzek MR; Taanman JW; Gschmeissner S; Schiavo G; Cooper JM; Warner TT
Mov Disord; 2005 Apr; 20(4):432-440. PubMed ID: 15593317
[TBL] [Abstract][Full Text] [Related]
16. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics.
Hewett JW; Zeng J; Niland BP; Bragg DC; Breakefield XO
Neurobiol Dis; 2006 Apr; 22(1):98-111. PubMed ID: 16361107
[TBL] [Abstract][Full Text] [Related]
17. Unraveling cellular phenotypes of novel TorsinA/TOR1A mutations.
Vulinovic F; Lohmann K; Rakovic A; Capetian P; Alvarez-Fischer D; Schmidt A; Weißbach A; Erogullari A; Kaiser FJ; Wiegers K; Ferbert A; Rolfs A; Klein C; Seibler P
Hum Mutat; 2014 Sep; 35(9):1114-22. PubMed ID: 24931141
[TBL] [Abstract][Full Text] [Related]
18. Dystonia-associated protein torsinA is not detectable at the nerve terminals of central neurons.
Koh JY; Iwabuchi S; Harata NC
Neuroscience; 2013 Dec; 253():316-29. PubMed ID: 24025868
[TBL] [Abstract][Full Text] [Related]
19. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
Goodchild RE; Dauer WT
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):847-52. PubMed ID: 14711988
[TBL] [Abstract][Full Text] [Related]
20. Advances in molecular and cell biology of dystonia: Focus on torsinA.
Gonzalez-Alegre P
Neurobiol Dis; 2019 Jul; 127():233-241. PubMed ID: 30877032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
